Last reviewed · How we verify

MET097 Injection — Competitive Intelligence Brief

MET097 Injection (met097-injection) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: unknown.

marketed unknown unknown Peptide Live · refreshed every 30 min

Target snapshot

MET097 Injection (met097-injection) — Pfizer Inc.. MET097 Injection's mechanism of action is not specified.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
MET097 Injection TARGET met097-injection Pfizer Inc. marketed unknown unknown
SINECATECHINS SINECATECHINS marketed Polyphenols Unknown 2006-01-01
PODOFILOX PODOFILOX marketed Topical antiviral Unknown 1990-01-01
POLIDEXIDE SULFATE POLIDEXIDE SULFATE marketed Unknown Unknown 1974-01-01
SUTILAINS SUTILAINS marketed Unknown Unknown 1969-01-01
Pf-07923568 pf-07923568 Pfizer marketed Unknown pharmacological class Unknown target
Pf-08046037 pf-08046037 Pfizer marketed Unknown Unknown

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape (unknown class)

  1. Pfizer · 7 drugs in this class
  2. Pfizer Inc. · 3 drugs in this class
  3. Qilu Pharmaceutical Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). MET097 Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/met097-injection. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: